These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23424631)

  • 1. A novel synthetic receptor-based immunoassay for influenza vaccine quantification.
    Hashem AM; Gravel C; Farnsworth A; Zou W; Lemieux M; Xu K; Li C; Wang J; Goneau MF; Merziotis M; He R; Gilbert M; Li X
    PLoS One; 2013; 8(2):e55428. PubMed ID: 23424631
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay.
    Lorbetskie B; Cunningham AM; Lemieux M; Durno L; Farnsworth A; Wang J; Li C; Li X; Gilbert M; Sauvé S; Girard M
    Anal Chem; 2019 Jul; 91(14):8908-8917. PubMed ID: 31251585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
    Khurana S; King LR; Manischewitz J; Coyle EM; Golding H
    Vaccine; 2014 Apr; 32(19):2188-97. PubMed ID: 24613520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance.
    Mandenius CF; Wang R; Aldén A; Bergström G; Thébault S; Lutsch C; Ohlson S
    Anal Chim Acta; 2008 Aug; 623(1):66-75. PubMed ID: 18611459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
    Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C; Shao M; Cui X; Song Y; Li J; Yuan L; Fang H; Liang Z; Cyr TD; Li F; Li X; Wang J
    Biologicals; 2010 Mar; 38(2):284-9. PubMed ID: 20074976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
    PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
    Schmeisser F; Vasudevan A; Soto J; Kumar A; Williams O; Weir JP
    Influenza Other Respir Viruses; 2014 Sep; 8(5):587-95. PubMed ID: 25087462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F; Jing X; Joshi M; Vasudevan A; Soto J; Li X; Choudhary A; Baichoo N; Resnick J; Ye Z; McCormick W; Weir JP
    Influenza Other Respir Viruses; 2016 Mar; 10(2):134-40. PubMed ID: 26616263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J; Vandenberg K; Laurie K; Barr IG; Zhang Y; Rockman S
    Front Immunol; 2023; 14():1147028. PubMed ID: 37033922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs.
    Bonificio A; Ghartey-Tagoe E; Gallorini S; Baudner B; Chen G; Singh P; O'Hagan DT; Kommareddy S
    Vaccine; 2015 Jun; 33(25):2930-8. PubMed ID: 25930118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines.
    Sun X; Cao W; Pappas C; Liu F; Katz JM; Tumpey TM
    Virology; 2014 Sep; 464-465():156-165. PubMed ID: 25078114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage.
    Hickey JM; Holtz KM; Manikwar P; Joshi SB; McPherson CE; Buckland B; Srivastava IK; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):821-7. PubMed ID: 24425059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y; Palladino G; Xie Y; Ferrari A; Ma X; Han L; Dormitzer PR; Settembre EC
    Vaccine; 2016 Jun; 34(29):3388-95. PubMed ID: 27154389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Chae W; Kim P; Hwang BJ; Seong BL
    Vaccine; 2019 Mar; 37(11):1457-1466. PubMed ID: 30765169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin.
    Eichelberger SL; Sultana I; Gao J; Getie-Kebtie M; Alterman M; Eichelberger MC
    Influenza Other Respir Viruses; 2013 Nov; 7(6):961-8. PubMed ID: 23496824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.